ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 37 filers reported holding ENZYMOTEC LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | +25.0% | 400 | -20.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 500 | +25.0% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -99.6% | 400 | -99.6% | 0.00% | – |
| Q4 2015 | $984,000 | +8.3% | 100,400 | 0.0% | 0.00% | – |
| Q3 2015 | $909,000 | +8.5% | 100,400 | 0.0% | 0.00% | – |
| Q2 2015 | $838,000 | +27833.3% | 100,400 | +25000.0% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | 0.0% | 400 | -20.0% | 0.00% | – |
| Q3 2014 | $3,000 | -97.2% | 500 | -93.7% | 0.00% | – |
| Q2 2014 | $108,000 | +33.3% | 7,965 | +116.0% | 0.00% | – |
| Q1 2014 | $81,000 | +326.3% | 3,687 | +417.8% | 0.00% | – |
| Q4 2013 | $19,000 | – | 712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |